Member Info for xviolet

Yes. Thank you. Sold a few. Also holding some.
And will make a donation to North London Hospice to say bigger thanks.
But yes thank you very much!!!! 40-60% rise is great to see. OEX also went crazy today.

4.4 million SAR is 280K.

SP could be good entry point. Been on a downwards trend from recent highs.
Yesterday someone dumped 4.4 million shares. Price up a little today.

adfvn says 14,908,497 today.
seems like an interesting figure.
would welcome any perspectives.

Aberystwyth

thanks. I should have worked it out myself but appreciate your reply.
thanks again.

Thanks. I will buy some more.
Any idea how many SAR shares you would have to buy before you have to issue a TR-1?
Thoth suggested an institution was buying. If that's the case then this is surely the last time we'll see these prices for a long time.

the trades are interesting. they speak.
we are looking at a series of 500,000 buys?
is that correct?

paid.
keep going.

An institution buying SAR? Thats a first, I think. Is that right?
In which case, when TR-1 comes....this will boom. Although anyone is very welcome to correct me.
Thank you.

actually it was 6.60 I paid.
will buy some more later I guess.

6.85 paid

Did I read someone here the other day saying they hoped to buy sub 6p? Chance would be a fine etc. First time I bought HE1 back in March I paid 7.03p. Just bought some more yesterday for 8.60p. And will continue to buy in small tranches, every now and again. I read a piece by Sir Jeremy Grantham who said you can never catch the bottom. And presumably you will never sell at the top. So I don't let that issue get to me. Just do what you can.

Recovery pharma is an interesting category.
Seres did 16% yesterday. Polyphor at a historic low.

Sits nicely with the Coviferom results (article in Nature publ April 2021).
https://www.nature.com/articles/s41598-021-86859-y

"...it is heavily postulated that SARS-CoV-2 may also inhibit the type I IFNs in the early phase of COVID-19 disease.... Accordantly, we found a meaningful correlation between the administration of IFNß1a and the alleviation of the clinical course of COVID-19 disease. This observation was of particular importance, since it could propose IFN as a potent therapeutic option in severe COVID-19 cases.

....we can argue that the future trials should be focused on both types of the IFNs; even with a bigger emphasis on IFNß1a."

Was someone saying the price was being dropped to make way for a huge order? Hope so. And then a TR-1 from an institution to follow. That would be nice. One more Polygon or related institution RNS and this would explode.

165 paid.
a bit less now. but you can never catch the bottom (or the top!)

RNS out. Reads positive (although I usually mis-interpret RNS's)

RNS out. this morning.

Very exuberant on the Synairgen board. I plan to sell some of my Synairgen shares into the exuberance - a de-risking move - but would be pleased to hear any alternate strategies/suggestions.

I'm patient about this. Buy a few every now and again - the sp has been quite obliging, today for instance.